Fulgent Genetics Stock Technical Analysis
| FLGT Stock | USD 23.54 0.17 0.72% |
As of the 6th of February, Fulgent Genetics shows the Coefficient Of Variation of 2427.96, downside deviation of 1.81, and Mean Deviation of 1.79. Fulgent Genetics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Fulgent Genetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Fulgent, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FulgentFulgent Genetics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Fulgent Genetics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 33.67 | Buy | 3 | Odds |
Most Fulgent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Fulgent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Fulgent Genetics, talking to its executives and customers, or listening to Fulgent conference calls.
Is there potential for Health Care Providers & Services market expansion? Will Fulgent introduce new products? Factors like these will boost the valuation of Fulgent Genetics. Market participants price Fulgent higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (1.37) | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
Investors evaluate Fulgent Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Fulgent Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Fulgent Genetics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Fulgent Genetics' market price signifies the transaction level at which participants voluntarily complete trades.
Fulgent Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fulgent Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fulgent Genetics.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Fulgent Genetics on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Fulgent Genetics or generate 0.0% return on investment in Fulgent Genetics over 90 days. Fulgent Genetics is related to or competes with Myriad Genetics, Personalis, DarioHealth Corp, Castle Biosciences, CareDx, Butterfly Network, and Arvinas. Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing ser... More
Fulgent Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fulgent Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fulgent Genetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.81 | |||
| Information Ratio | 0.0265 | |||
| Maximum Drawdown | 21.74 | |||
| Value At Risk | (2.59) | |||
| Potential Upside | 4.24 |
Fulgent Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fulgent Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fulgent Genetics' standard deviation. In reality, there are many statistical measures that can use Fulgent Genetics historical prices to predict the future Fulgent Genetics' volatility.| Risk Adjusted Performance | 0.0385 | |||
| Jensen Alpha | 0.0965 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0449 | |||
| Treynor Ratio | 0.2036 |
Fulgent Genetics February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0385 | |||
| Market Risk Adjusted Performance | 0.2136 | |||
| Mean Deviation | 1.79 | |||
| Semi Deviation | 1.73 | |||
| Downside Deviation | 1.81 | |||
| Coefficient Of Variation | 2427.96 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.45 | |||
| Information Ratio | 0.0265 | |||
| Jensen Alpha | 0.0965 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0449 | |||
| Treynor Ratio | 0.2036 | |||
| Maximum Drawdown | 21.74 | |||
| Value At Risk | (2.59) | |||
| Potential Upside | 4.24 | |||
| Downside Variance | 3.29 | |||
| Semi Variance | 3.01 | |||
| Expected Short fall | (2.59) | |||
| Skewness | 3.26 | |||
| Kurtosis | 18.27 |
Fulgent Genetics Backtested Returns
Fulgent Genetics secures Sharpe Ratio (or Efficiency) of -0.0975, which denotes the company had a -0.0975 % return per unit of risk over the last 3 months. Fulgent Genetics exposes twenty-six different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fulgent Genetics' Mean Deviation of 1.79, downside deviation of 1.81, and Coefficient Of Variation of 2427.96 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.57, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fulgent Genetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fulgent Genetics is expected to be smaller as well. At this point, Fulgent Genetics has a negative expected return of -0.2%. Please make sure to confirm Fulgent Genetics' sortino ratio, as well as the relationship between the downside variance and rate of daily change , to decide if Fulgent Genetics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
Fulgent Genetics has below average predictability. Overlapping area represents the amount of predictability between Fulgent Genetics time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fulgent Genetics price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Fulgent Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 1.56 |
Fulgent Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Fulgent Genetics Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Fulgent Genetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Fulgent Genetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Fulgent Genetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Fulgent Genetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Fulgent Genetics price pattern first instead of the macroeconomic environment surrounding Fulgent Genetics. By analyzing Fulgent Genetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Fulgent Genetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Fulgent Genetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0202 | 0.018 | Price To Sales Ratio | 2.27 | 2.15 |
Fulgent Genetics February 6, 2026 Technical Indicators
Most technical analysis of Fulgent help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fulgent from various momentum indicators to cycle indicators. When you analyze Fulgent charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0385 | |||
| Market Risk Adjusted Performance | 0.2136 | |||
| Mean Deviation | 1.79 | |||
| Semi Deviation | 1.73 | |||
| Downside Deviation | 1.81 | |||
| Coefficient Of Variation | 2427.96 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.45 | |||
| Information Ratio | 0.0265 | |||
| Jensen Alpha | 0.0965 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0449 | |||
| Treynor Ratio | 0.2036 | |||
| Maximum Drawdown | 21.74 | |||
| Value At Risk | (2.59) | |||
| Potential Upside | 4.24 | |||
| Downside Variance | 3.29 | |||
| Semi Variance | 3.01 | |||
| Expected Short fall | (2.59) | |||
| Skewness | 3.26 | |||
| Kurtosis | 18.27 |
Fulgent Genetics February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Fulgent stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 23.54 | ||
| Day Typical Price | 23.54 | ||
| Price Action Indicator | (0.09) |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.